DAG181
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for DAG181, covering 2018-08-01 to 2021-02-18. Get the full timeline:
Most recent: Clinical Trial Update: To Evaluate Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in HCV Genotype I Infected Patients [Phase 2]